Corrigendum to “The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer” [Breast 52 (2020) 102–109]
Mark van Barele,
Bernadette A.M. Heemskerk-Gerritsen,
Helena C. van Doorn,
Marjanka K. Schmidt,
Maartje J. Hooning,
Agnes Jager
Affiliations
Mark van Barele
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
Bernadette A.M. Heemskerk-Gerritsen
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
Helena C. van Doorn
Department of Gynecological Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
Marjanka K. Schmidt
Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Department of Epidemiology, Leiden University, Leiden, the Netherlands
Maartje J. Hooning
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Corresponding author.
Agnes Jager
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands
